Skip to main content

Advertisement

SpringerLink
Log in

The Prevalence and Range of Major Cardiovascular Risk Factors in Iranian Diabetic Adults

  • Medicine
  • Published:
SN Comprehensive Clinical Medicine Aims and scope Submit manuscript

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death in most countries. Diabetic patients have a greater risk for CVDs. The aim of this study was to assess the prevalence and range of major CVD risk factors among diabetic patients receiving preventive and curative treatment at a diabetes clinic of Shariati Hospital based on gender and age. Four hundred eighteen diabetic participants aged 30–74 years old entered this cross-sectional study. Information about smoking habits, blood pressure, presence/absence of being under hypertension treatment, and lipid profiles was collected from each patient’s medical record and SPSS version 20 was used for data analysis. The mean age of participants was 59.8 years. Smoking prevalence was 4.3%. Mean blood pressure was 121.5/79.2 mmHg. Mean total cholesterol was 152.2 mg/dl, low-density lipoprotein cholesterol(LDL-C) was 83.1 mg/dl, high-density lipoprotein cholesterol(HDL-C) was 45.4 mg/dl, and non-HDL cholesterol was 106.7 mg/dl. The prevalence of normal LDL-C was 87.3% and 77.4% in men and women, respectively (P = 0.01). Women had abnormal HDL-C levels more frequently than men (60.3% vs. 45.2%, P = 0.002). Most non-HDL levels were in normal spectrum (90.4% of males vs. 79.8% of females, P = 0.04). In individuals older than 65 years, normal values were more than abnormal ones except for females’ HDL-C. The results showed that most of the patients had normal ranges for CVD risk factors and more attention for HDL control is needed. Multiple supplementary prospective studies must have been done to investigate the exact situation of risk factors’ range among diabetic patients that receive preventive and curative treatment for CVD reduction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9(1):167.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Saadat S, Yousefifard M, Asady H, Jafari AM, Fayaz M, Hosseini M. The most important causes of death in Iranian population; a retrospective cohort study. Emergency. 2015;3(1):16–21.

    PubMed  PubMed Central  Google Scholar 

  3. Tuppin P, Rivière S, Rigault A, Tala S, Drouin J, Pestel L, et al. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database. Arch Cardiovasc Dis. 2016;109(6–7):399–411.

    Article  PubMed  Google Scholar 

  4. Golozar A, Khademi H, Kamangar F, Poutschi H, Islami F, Abnet CC, et al. Diabetes mellitus and its correlates in an Iranian adult population. PLoS One. 2011;6(10):e26725.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall EE. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res. 2002;53(3):538–49.

    Article  CAS  PubMed  Google Scholar 

  6. Bosomworth NJ. Practical use of the Framingham risk score in primary prevention: Canadian perspective. Can Fam Physician. 2011;57(4):417–23.

    PubMed  PubMed Central  Google Scholar 

  7. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100(10):1134–46.

    Article  CAS  PubMed  Google Scholar 

  8. Franquesa M, Pujol-Busquets G, García-Fernández E, Rico L, Shamirian-Pulido L, Aguilar-Martínez A, et al. Mediterranean diet and cardiodiabesity: a systematic review through evidence-based answers to key clinical questions. Nutrients. 2019;11(3):655.

    Article  CAS  PubMed Central  Google Scholar 

  9. Rees K, Takeda A, Martin N, Ellis L, Wijesekara D, Vepa A, et al. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. (2019, 3).

  10. Hanson M. The inheritance of cardiovascular disease risk. Acta Paediatr. 2019.

  11. Moosazadeh M, Amiresmaili M, Afshari M. Individual patient data meta-analysis of the smoking prevalence in Mazandaran Province of Iran. Iran Red Crescent Med J. 2015;17(2):e10294.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Moosazadeh M, Ziaaddini H, Mirzazadeh A, Ashrafi-Asgarabad A, Haghdoost AA. Meta-analysis of smoking prevalence in Iran. Addict Health. 2013;5(3–4):140–53.

    PubMed  PubMed Central  Google Scholar 

  13. Ardeshiri MJ, Moosazadeh M, Masouleh MF, Masouleh MF, Kiani A, Fakhri M. Prevalence of smoking in 15-64 years old population of north of Iran: meta-analysis of the results of non-communicable diseases risk factors surveillance system. Acta Med Iran. 2013;51(7):494–500.

    Google Scholar 

  14. Ghaffari S, Pourafkari L, Tajlil A, Sahebihagh MH, Mohammadpoorasl A, Tabrizi JS, et al. The prevalence, awareness and control rate of hypertension among elderly in northwest of Iran. J Cardiovasc Thoracic Res. 2016;8(4):176–82.

    Article  Google Scholar 

  15. Stryjewski P, Januś B, Krupa E, Nessler B, Badacz L, Nessler J. Prevalence of age, gender and body weight on the frequency of hypertension and diabetes mellitus in patients hospitalized in cardiology department. Przeglad lekarski. 2011;68(9):585–7.

    PubMed  Google Scholar 

  16. Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980–2012: a systematic review. J Tehran Univ Heart Center. 2016;11(4):159–67.

    Google Scholar 

  17. Farid SM. Gender-related differences in lipid profile and atherogenic indices in patients with type 2 diabetes mellitus in Jeddah, Saudi Arabia. Glob J Bio-Sci Biotechnol. 2017;6(3):430–8.

    Google Scholar 

  18. Nakhjavani M, Esteghamati A, Heshmat FEA. Dyslipidemia in type 2 diabetes mellitus: more atherogenic lipid profile in women. Acta Med Iran. 2006;44(2):111–8.

    Google Scholar 

  19. Yeasmin R, Nahar N, Muttalib M, Bhuiyan MNH, Zahid AZR, Jahan WA. Gender variation of lipid profiles of type-2 diabetes mellitus patients attended at a specialized diabetic hospital in Dhaka. J Curr Adv Med Res. 2015;2(2):34–8.

    Article  Google Scholar 

  20. Alsaadi M, Qassim S, Hamad F, Metwali Z. Pattern of dyslipidaemia in patients with type 2 diabetes mellitus in Fujairah, United Arab Emirates. Eur J Pharma Med Res. 2016;3(2):340–7.

    Google Scholar 

  21. Mohammadbeigi A, Moshiri E, Mohammadsalehi N, Ansari H, Ahmadi A. Dyslipidemia prevalence in Iranian adult men: the impact of population-based screening on the detection of undiagnosed patients. World J Men’s Health. 2015;33(3):167–73.

    Article  Google Scholar 

  22. Palazhy S, Viswanathan V. Lipid abnormalities in type 2 diabetes mellitus patients with overt nephropathy. Diabetes Metab J. 2017;41(2):128–34.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to thank all colleagues in Shariati Hospital’s diabetes clinic and laboratory for their support in this research.

Author information

Authors and Affiliations

  1. Medical Faculty, Islamic Azad University of Najafabad, Isfahan, Iran

    Nazanin Alaei Faradonbeh

  2. Department of Cardiology, Medical faculty, Islamic Azad University of Najafabad, Isfahan, Iran

    Fariborz Nikaeen

  3. Isfahan University of Medical Science, Isfahan, Iran

    Mojtaba Akbari

  4. Central Laboratory of Shariati Hospital, Isfahan, Iran

    Naser Almasi

  5. Heart Failure Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

    Mehrbod Vakhshoori

Authors
  1. Nazanin Alaei Faradonbeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fariborz Nikaeen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mojtaba Akbari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naser Almasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mehrbod Vakhshoori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mehrbod Vakhshoori.

Ethics declarations

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Conflict of Interests

All authors declare that they had no conflict of interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Medicine

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faradonbeh, N.A., Nikaeen, F., Akbari, M. et al. The Prevalence and Range of Major Cardiovascular Risk Factors in Iranian Diabetic Adults. SN Compr. Clin. Med. 1, 517–522 (2019). https://doi.org/10.1007/s42399-019-00075-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42399-019-00075-4

Keywords

Search

Navigation